Mounjaro - the brand name for tirzepatide - has become one of the most talked-about medications in metabolic health, and for good reason. But the conversation around it has gotten tangled up with ...

GLP-1 drugs are driving major weight loss trends, but doctors warn that rapid weight loss may affect nutrition, bone density, heart health, and blood sugar balance.

Experts warn that 1 in 10,000 Wegovy users face a fivefold higher risk of serious eye complications, including permanent vision loss, compared to Ozempic.

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

Hims & Hers Health, Inc.'s revenue is projected to reach $2.7B in 2026 & $3.2B in 2027, implying less than 2x forward sales. Read more on HIMS stock here.

Weight-loss jab Wegovy may pose the highest risk of sudden sight loss when compared to other jabs of a similar nature, such as Ozempic, according to a new analysis. The study also revealed that men ...

Now, a new analysis has revealed Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs. The odds of having a so-called 'eye stroke' were also three times higher in ...

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in ...

The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as Ozempic, according to new analysis. The odds of having a so-called “eye stroke” ...

Drugs based on semaglutide have become some of the most talked-about medicines in recent years. These drugs belong to a class ...

Wegovy users have five times the risk of experiencing permanent sight loss linked to weight loss jabs than those taking other ...

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in both eyes.